2014
DOI: 10.1002/bdrc.21062
|View full text |Cite
|
Sign up to set email alerts
|

Chondrocyte hypertrophy in skeletal development, growth, and disease

Abstract: Most of our bones form through the process of endochondral ossification, which is tightly regulated by the activity of the cartilage growth plate. Chondrocyte maturation through the various stages of growth plate physiology ultimately results in hypertrophy. Chondrocyte hypertrophy is an essential contributor to longitudinal bone growth, but recent data suggest that these cells also play fundamental roles in signaling to other skeletal cells, thus coordinating endochondral ossification. On the other hand, ecto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
118
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 114 publications
(124 citation statements)
references
References 77 publications
2
118
0
Order By: Relevance
“…Such responses include upregulation of inflammatory mediators that leads to cartilage extracellular matrix (ECM) degradation via increased expression of matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) (2327). Chondrocyte phenotype also changes during catabolism including cell clustering/proliferation (28), apoptosis, and/or hypertrophic differentiation with increased expression of markers such as Col10a1 , Runx2 , and Mmp13 (29,30). A number of gene polymorphisms have been reported in human OA (e.g., GDF5 , SMAD3 ) (31,32), and there are now several, robustly replicated, significant OA loci that have been identified by large-scale genome-wide association studies (GWASs) (3335).…”
Section: Oa Pathologymentioning
confidence: 99%
“…Such responses include upregulation of inflammatory mediators that leads to cartilage extracellular matrix (ECM) degradation via increased expression of matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) (2327). Chondrocyte phenotype also changes during catabolism including cell clustering/proliferation (28), apoptosis, and/or hypertrophic differentiation with increased expression of markers such as Col10a1 , Runx2 , and Mmp13 (29,30). A number of gene polymorphisms have been reported in human OA (e.g., GDF5 , SMAD3 ) (31,32), and there are now several, robustly replicated, significant OA loci that have been identified by large-scale genome-wide association studies (GWASs) (3335).…”
Section: Oa Pathologymentioning
confidence: 99%
“…Stratification of chondrocytes in various states of maturity causes formation of the growth plate, in which the most mature cells cease proliferating and undergo hypertrophy. This critical milestone in the process of endochondral ossification is typified by characteristic changes in chondrocyte morphology, including dramatic increases in cell volume, and a defined gene expression profile (Man-Ger Sun and Beier, 2014). Hypertrophic chondrocytes begin to produce a very specialized matrix consisting of collagen type X (Col10) and express alkaline phosphatase (Alk Phos), and matrix calcification is initiated (Adams et al, 2007;van der Eerden et al, 2003;Anderson et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Destruction of cartilage, loss of cartilage matrix, aberrant chondrocyte hypertrophy, 1,2 and disruption of the tidemark accompanied by angiogenesis at the osteochondral junction 3 are characteristics of OA. Unfortunately, no effective medical therapy for the condition is available for clinical use because of limited understanding of its pathogenesis.…”
Section: Introductionmentioning
confidence: 99%